CellaVision AB (publ)

CLVSF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$39,226$47,995$52,501$51,489
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$22,762$7,502$3,578-$14,300
Other Non-Cash$13,162$2,555$5,347$8,804
Operating Cash Flow$29,626$58,052$61,426$45,993
Investing Activities
PP&E Inv.-$22,200-$24,819-$21,384-$25,123
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$7-$219$192$755
Investing Cash Flow-$22,193-$25,038-$21,192-$24,368
Financing Activities
Debt Repay.-$403-$421-$395-$7,211
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0-$59,629$0$0
Other Fin. Act.-$3,401-$3,410-$3,090-$3,150
Financing Cash Flow-$3,804-$63,460-$3,485-$10,361
Forex Effect-$242$3,410-$3,862$504
Net Chg. in Cash$3,387-$27,036$32,887$11,767
Supplemental Information
Beg. Cash$155,281$182,317$149,430$137,663
End Cash$158,668$155,281$182,317$149,430
Free Cash Flow$7,426$33,233$40,042$20,870